Relay Therapeutics, Inc. (RLAY) Shareholders’ equity 2020–2025
Relay Therapeutics, Inc. (RLAY) shareholders’ equity at each fiscal year-end, per SEC filings.
$567.1MFY2025 · since FY2020: $763.3M → $567.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $567.1M | -27.1% |
| FY2024 | $777.8M | +3.4% |
| FY2023 | $752.0M | -20.9% |
| FY2022 | $950.2M | +5.8% |
| FY2021 | $897.8M | +17.6% |
| FY2020 | $763.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice